BP11109 PTMC, Poly(trimethylene carbonate), Hydroxyl Terminated, IV: 5.0–6.0 dl/g, Mw: 378–477 kDa

PTMC, Poly(trimethylene carbonate), Hydroxyl Terminated, IV: 5.0–6.0 dl/g, Mw: 378–477 kDa Description

The product is a hydroxyl terminated poly(trimethylene carbonate) with an intrinsic viscosity ranging from 5.0 to 6.0 dl/g and a weight average molecular weight between 378 and 477 kDa. Production occurs under strict processing parameters to minimise batch variability. The defined specifications support predictable degradation behaviour and mechanical performance, making it suitable for tissue engineering, drug delivery systems, and other advanced biocompatible applications.

PTMC, Poly(trimethylene carbonate), Hydroxyl Terminated, IV: 5.0–6.0 dl/g, Mw: 378–477 kDa Applications

1.         Healthcare
   - Used as a scaffold matrix in tissue engineering to achieve controlled degradation by leveraging its predictable resorption properties.
   - Applied in controlled drug release systems to manage therapeutic dosing through its defined polymer degradation rate.

2.         Biomedical Devices
   - Employed as a coating component in implantable devices to improve flexibility and reduce inflammatory responses by leveraging its biocompatible and resorbable nature.

PTMC, Poly(trimethylene carbonate), Hydroxyl Terminated, IV: 5.0–6.0 dl/g, Mw: 378–477 kDa Packing

The polymer is packaged in moisture-resistant, sealed containers to prevent contamination and degradation. Each package is lined with anti-static materials to minimise particulate exposure. It is recommended to store the product in a cool, dry, and dark environment to maintain its integrity. Customised packaging options are available to accommodate varying order sizes and shipping requirements.

Additional Information

PTMC, Poly(trimethylene carbonate), is a biodegradable and biocompatible polymer widely studied in the field of biomedical materials. Known for its amorphous nature, it exhibits excellent biocompatibility and biodegradability, and remains in a rubbery state with inherent elasticity at body temperature. Its adjustable degradation profile and processability make it well-suited for applications such as soft tissue engineering, flexible implants, and controlled drug delivery systems. Understanding the relationship between its molecular weight and intrinsic viscosity is essential for tailoring its performance in specific biomedical and industrial contexts.

The presence of hydroxyl end groups provides reactive sites for further chemical modification, covalent conjugation, or chain extension, thereby enhancing its versatility in synthesising block copolymers, cross-linked networks, and functionalised biomaterials. This reactive functionality expands its utility in advanced manufacturing, formulation processes, and the development of customised polymeric systems. Ongoing research continues to refine processing techniques to enhance its performance, reliability, and reproducibility across a growing range of applications.

Regulatory Note: This material is intended for industrial and research applications. It is the customer's responsibility to ensure compliance with all relevant safety and regulatory standards in their intended use.